EGFR and cancer: Indeed, the EGFR and ERBB families (ERBB2, ERBB3 and ERBB4) were also ranked in the top 10 cancer driver targets in the transcriptional networking, suggesting their roles in uPAR-mediated tumorigenesis processes were highly anticipated.